Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00064233
What this trial is testing

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center 42
Testing effectiveness (Phase 2)WithdrawnNCT02923986
What this trial is testing

Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS

Who this might be right for
Chronic Myelogenous Leukemia, Ph1-PositiveAcute Myeloid LeukemiaMyelodysplastic Syndrome
Bio-Path Holdings, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00362466
What this trial is testing

Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy

Who this might be right for
Leukemia
Bristol-Myers Squibb 3
Testing effectiveness (Phase 2)Study completedNCT00103844
What this trial is testing

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia
Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)Ended earlyNCT00005986
What this trial is testing

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)UnknownNCT00008307
What this trial is testing

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Herbert Irving Comprehensive Cancer Center 52
Not applicableUnknownNCT03709017
What this trial is testing

Iclusig PMS in CML or Ph+ALL Patients

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Korea Otsuka Pharmaceutical Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT00101660
What this trial is testing

Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia
Bristol-Myers Squibb 387
Testing effectiveness (Phase 2)Study completedNCT00254423
What this trial is testing

Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 150
Not applicableUnknownNCT00445822
What this trial is testing

Registration of Children With CML and Treatment With Imatinib

Who this might be right for
Myeloid Leukemia, Chronic
Technische Universität Dresden 150
Not applicableStudy completedNCT03454503
What this trial is testing

Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Who this might be right for
Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Hikma Pharmaceuticals LLC 173
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191
What this trial is testing

Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Ended earlyNCT00022490
What this trial is testing

Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT01275196
What this trial is testing

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 267
Post-approval studies (Phase 4)Study completedNCT01243489
What this trial is testing

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

Who this might be right for
Chronic Myelogenous Leukemia (CML)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Post-approval studies (Phase 4)Study completedNCT00980018
What this trial is testing

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Study completedNCT00123487
What this trial is testing

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Who this might be right for
Myeloid Leukemia, Chronic, Accelerated PhaseLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Bristol-Myers Squibb 638
Testing effectiveness (Phase 2)Study completedNCT00006052
What this trial is testing

STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Novartis
Testing effectiveness (Phase 2)Study completedNCT00337454
What this trial is testing

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

Who this might be right for
Chronic Myelogenous Leukemia
Bristol-Myers Squibb 48
Next Page